2602 PUBLICATIONS
ANNÉE
JOURNAL
PREMIER AUTEUR
TITRE
ANNÉE2020
JOURNALAdvances in colloid and interface science
PREMIER AUTEURBizeau J
TITREDesign and applications of protein delivery systems in nanomedicine and tissue engineering.
ANNÉE2020
JOURNALInternational journal of molecular sciences
PREMIER AUTEUREve L
TITREExposure to Endocrine Disrupting Chemicals and Risk of Breast Cancer.
ANNÉE2020
JOURNALJournal of thrombosis and thrombolysis
PREMIER AUTEURPluchart C
TITREA pilot study of procoagulant platelet extracellular vesicles and P-selectin increase during induction treatment in acute lymphoblastic leukaemia paediatric patients: two new biomarkers of thrombogenic risk?
ANNÉE2020
JOURNALJournal of clinical medicine
PREMIER AUTEURLecointre L
TITREDiagnostic Accuracy and Clinical Impact of Sentinel Lymph Node Sampling in Endometrial Cancer at High Risk of Recurrence: A Meta-Analysis.
ANNÉE2020
JOURNALTrends in cancer
PREMIER AUTEURGensbittel V
TITRENanoluminal Signaling Shapes Collective Metastasis.
ANNÉE2020
JOURNALCancers
PREMIER AUTEURPerrichet A
TITREUnderstanding Inflammasomes and PD-1/PD-L1 Crosstalk to Improve Cancer Treatment Efficiency.
ANNÉE2020
JOURNALJournal of clinical medicine
PREMIER AUTEURLi S
TITRERisk Factors, Pathogenesis, and Strategies for Hepatocellular Carcinoma Prevention: Emphasis on Secondary Prevention and Its Translational Challenges.
ANNÉE2020
JOURNALJCI insight
PREMIER AUTEURHadi T
TITRELipoproteins LDL versus HDL as nanocarriers to target either cancer cells or macrophages.
ANNÉE2020
JOURNALBlood advances
PREMIER AUTEURVercellino L
TITREPredictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma.
ANNÉE2020
JOURNALPharmaceuticals (Basel, Switzerland)
PREMIER AUTEURDolat M
TITREAssociation of 5-FU Therapeutic Drug Monitoring to DPD Phenotype Assessment May Reduce 5-FU Under-Exposure.

Retrouvez aussi

Personnes
Equipes
Plateformes
Unités de recherche, établissements
Projets de recherche
Publications scientifiques